CTRI/2022/05/042920尚未招募未知
to evaluate in-vivo safety and efficacy of skin care formulationon healthy female subjects
MERCK PERFORMANCE MATERIALS PVT LTD0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1Indian or Asian female subjects
- •2Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup.
- •3Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar) Specific criteria
- •4Subjects having visible melasma, having crows feet wrinkles of grade 2 and above.
排除标准
- •1Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
- •2Having refused to give his/her assent by not signing the consent form and Informed consent form
- •3Taking part in another study liable to interfere with this study
- •4Being known diabetic case
- •5Known asthma
- •6Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis)
- •7Being known thyroid case
- •8Being epileptic.
- •9Following a chronic medicinal treatment comprising any of the following products: aspirin based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes or corticosteroid by any route (the only medication permitted is paracetamol)
- •10Known case of hypersensitivity.
- •11Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
- •12Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
- •13Having changed their cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit.
- •14Having applied a cosmetic product (included make-up) on the studied areas 48 hours prior study
- •Having started, changed or stopped a hormonal treatment (hormonal contraception, Hormone Replacement Therapy, thyroidâ?¦) in the past 3 months.
- •16Having taken an oral retinoid-based treatment in the past 6 months
- •17Having taken a local retinoid-based treatment on the studied areas in the previous month
- •18Having had beauty treatment (e.g. scrub, manicure, self-tanning product â?¦) in the previous week
- •19Having practiced water activities (swimming pool, sauna, hammam, baleneotherapy etc.) in the previous week.
- •20Having consumed caffeine-based products (coffee, cola, tea, â?¦), alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements
- •21Having practiced intensive sports during the day prior to the T0 measurements
- •22Having wounds, Scars, sunburns, tattoos and piercing on test site.
- •23 Having hair on test site.
- •24Having applied another product than water on the studied areas in the morning of the T0 measurements
- •25Having had an intensive UV exposition on the inner forearm (solariums, sun) prior to T0 measurements.
- •26Having used cosmetic product on the studied area during 24 hours prior to T0 measurements.
研究者
相似试验
已完成
不适用
safety & efficacy of skin care formulatioCTRI/2018/02/012199ITC LIMITED ITC Life Sciences and Technology Centre39
已完成
4 期
To evaluate the effect and skin safety of 2 test products [cream containing Sodium Fusidate IP equivalent to Fusidic acid 0.25% w/w in the morning and cream containing Nicotinamide IP 4% w/w in the night] on subjects with moderate pimples on faceCTRI/2013/06/003766Apex Laboratories Pvt Ltd42
已完成
不适用
To assess the safety of test products on skiCTRI/2022/02/040014ITC LIMITED ITC Life Sciences and Technology Centre24
已完成
Unknown
Checking of safety of productsCTRI/2024/04/065604ITC LIMITED24
已完成
不适用
Safety assessment of test products on skiCTRI/2022/06/043465ITC LIMITED ITC Life Sciences and Technology Centre23